Sills MR. Leveraging SAFTINet resources to enhance value in performance measurement. Annual Convocation of the Scalable Architecture for Federated Translational Inquiries Network (SAFTINet). Aurora, Colorado, February 2014.
For more information on SAFTINet, please see http://www.ucdenver.edu/academics/colleges/medicalschool/programs/outcomes/COHO/saftinet/Pages/default.aspx
Academy Health- Annual Research Meeting - State Policy Interest Groups- 2013scherala
Title: Massachusetts Patient-Centered Medical Home Initiative (MA PCMHI): Impact on Clinical Quality at Midpoint
Authors: Judith Steinberg, Sai Cherala, Christine Johnson, Ann Lawthers.
Research Objective:
To assess the impact on clinical quality of practices’ participation in a Patient-Centered Medical Home (PCMH) demonstration. The MA PCMHI is a statewide, three-year, multi-payer demonstration of PCMH implementation in 45 primary care practices. Practices receive technical assistance including learning collaborative, coaching provided by external facilitators, and feedback of aggregated data, to support their implementation of PCMH processes. This study aims to assess the overall impact of this approach to transformation on a practice’s delivery of selected clinical services, including preventive care, care coordination and care management, and its processes and outcomes of care related to the initiative’s targeted conditions of diabetes and asthma at the midpoint of the initiative.
Academy Health- Annual Research Meeting - State Policy Interest Groups- 2013scherala
Title: Massachusetts Patient-Centered Medical Home Initiative (MA PCMHI): Impact on Clinical Quality at Midpoint
Authors: Judith Steinberg, Sai Cherala, Christine Johnson, Ann Lawthers.
Research Objective:
To assess the impact on clinical quality of practices’ participation in a Patient-Centered Medical Home (PCMH) demonstration. The MA PCMHI is a statewide, three-year, multi-payer demonstration of PCMH implementation in 45 primary care practices. Practices receive technical assistance including learning collaborative, coaching provided by external facilitators, and feedback of aggregated data, to support their implementation of PCMH processes. This study aims to assess the overall impact of this approach to transformation on a practice’s delivery of selected clinical services, including preventive care, care coordination and care management, and its processes and outcomes of care related to the initiative’s targeted conditions of diabetes and asthma at the midpoint of the initiative.
Person-centred care and patient activationNuffield Trust
Richard Owen, NHS England, and Dr Natalie Armstrong of the University of Leicester present on evaluating Person Centred Care through Patient Activation Measure (PAM).
Be There San Diego - Cardiovascular Disease Prevention, a Regional Quality Co...UCLA CTSI
2017 Southern California Dissemination, Implementation and Improvement (DII) Science Symposium
Be There San Diego: Improving Cardiovascular Disease Prevention through a Regional Quality Collaborative
Christine Thorne, MD, MPH - University of California, San Diego
Allen Fremont, MD, PhD - RAND Corporation; UCLA; VA Greater Los Angeles HealthCare System
For more information on DII, go to: https://ctsi.ucla.edu/patients-community/pages/dissemination_implementation_improvement
Delivery of eQIPP through a seven day working physiotherapy service for cardi...NHS Improving Quality
Delivery of eQIPP through a seven day working physiotherapy service for cardio-thoracic surgery patients
South Tees Hospitals NHS Foundation Trust
Poster from the 'Delivering NHS services, seven days a week' event held in Birmingham on 16 November 2013
More information about this event can be found at
http://www.nhsiq.nhs.uk/news-events/events/nhs-services-seven-days-a-week.aspx
Discover more about how the West of England AHSN is putting innovation at the heart of healthcare, improving patient outcomes and generating wealth for economic growth.
Exercise programs for people with dementia: What's the evidence?Health Evidence™
Health Evidence hosted a 90 minute webinar examining the effectiveness of exercise programs for people with dementia. Click here for access to the audio recording: https://youtu.be/jC8HhC2XFrE
Dorothy Forbes, Professor, Faculty of Nursing, University of Alberta, Edmonton led the session and presented findings from her latest Cochrane review:
Forbes, D., Forbes, S. C., Blake, C. M., Thiessen, E. J., & Forbes, S. (2015). Exercise programs for people with dementia. Cochrane Database of Systematic Reviews, 2015(4), CD006489.
As the population ages, the number of people suffering with dementia will also rise. Not only will this affect quality of life of people with dementia but will also increase the burden of family caregivers, community care, and residential care services. Exercise interventions have been identified as a potential way of reducing or delaying the progression of dementia and its symptoms. This review examines two questions: do exercise programs for older people with dementia improve cognition, activities of daily living (ADLs), challenging behaviour, depression, and mortality in older people with dementia? and; do exercise programs for older people with dementia have an indirect impact on family caregivers' burden, quality of life, and mortality?
Let's Talk Research 2015 - Michael Harrison Blount - An Action Research appro...NHSNWRD
An Action Research approach to facilitating the integration of best practice in the Assessment and Management of Diabetes Related Lower Limb Problems in India.
Michael Harrison-Blount MSc. BSc (Hons). MChS. MFPM RCPS (Glasg). CSci
Lecturer in Podiatry
School of Health SciencesUniversity of Salford
t: +44 0161 2953516
email; m.j.harrison-blount@salford.ac.uk | www.salford.ac.uk
Quality improvement is integral to the practice of medicine. Sometimes, QI strays over into clinical research. This presentation provides an overview of the intersection between QI and research
iWantGreatCare's 7th National Symposium - Building fantastic staff morale, improving quality and reducing costs - took place on Tuesday 21st June at The King's Fund, London.
NHS leaders share their experiences of how they are building excellence in their Trust, reducing costs and growing staff morale by listening to the voice of the patient.
View the slides from these well-regarded delegates:
Alwen Williams, Chief Exective, Barts Health NHS Trust
David Behan, Chief Executive, Care Quality Commission
Dr Nadeem Moghal, Medical Director, Barking, Havering and Redbridge University Hospitals NHS Trust
Liz Mouland, Chief Nurse, First Community Health and Care
Jeremy Howick, clinical epidemiologist and philosopher
How graduates can help students gain vital careers skills – a presentation by Professor Ella Ritchie, Deputy Vice-Chancellor at Newcastle University, at Convocation Weekend (18 June 2011).
Person-centred care and patient activationNuffield Trust
Richard Owen, NHS England, and Dr Natalie Armstrong of the University of Leicester present on evaluating Person Centred Care through Patient Activation Measure (PAM).
Be There San Diego - Cardiovascular Disease Prevention, a Regional Quality Co...UCLA CTSI
2017 Southern California Dissemination, Implementation and Improvement (DII) Science Symposium
Be There San Diego: Improving Cardiovascular Disease Prevention through a Regional Quality Collaborative
Christine Thorne, MD, MPH - University of California, San Diego
Allen Fremont, MD, PhD - RAND Corporation; UCLA; VA Greater Los Angeles HealthCare System
For more information on DII, go to: https://ctsi.ucla.edu/patients-community/pages/dissemination_implementation_improvement
Delivery of eQIPP through a seven day working physiotherapy service for cardi...NHS Improving Quality
Delivery of eQIPP through a seven day working physiotherapy service for cardio-thoracic surgery patients
South Tees Hospitals NHS Foundation Trust
Poster from the 'Delivering NHS services, seven days a week' event held in Birmingham on 16 November 2013
More information about this event can be found at
http://www.nhsiq.nhs.uk/news-events/events/nhs-services-seven-days-a-week.aspx
Discover more about how the West of England AHSN is putting innovation at the heart of healthcare, improving patient outcomes and generating wealth for economic growth.
Exercise programs for people with dementia: What's the evidence?Health Evidence™
Health Evidence hosted a 90 minute webinar examining the effectiveness of exercise programs for people with dementia. Click here for access to the audio recording: https://youtu.be/jC8HhC2XFrE
Dorothy Forbes, Professor, Faculty of Nursing, University of Alberta, Edmonton led the session and presented findings from her latest Cochrane review:
Forbes, D., Forbes, S. C., Blake, C. M., Thiessen, E. J., & Forbes, S. (2015). Exercise programs for people with dementia. Cochrane Database of Systematic Reviews, 2015(4), CD006489.
As the population ages, the number of people suffering with dementia will also rise. Not only will this affect quality of life of people with dementia but will also increase the burden of family caregivers, community care, and residential care services. Exercise interventions have been identified as a potential way of reducing or delaying the progression of dementia and its symptoms. This review examines two questions: do exercise programs for older people with dementia improve cognition, activities of daily living (ADLs), challenging behaviour, depression, and mortality in older people with dementia? and; do exercise programs for older people with dementia have an indirect impact on family caregivers' burden, quality of life, and mortality?
Let's Talk Research 2015 - Michael Harrison Blount - An Action Research appro...NHSNWRD
An Action Research approach to facilitating the integration of best practice in the Assessment and Management of Diabetes Related Lower Limb Problems in India.
Michael Harrison-Blount MSc. BSc (Hons). MChS. MFPM RCPS (Glasg). CSci
Lecturer in Podiatry
School of Health SciencesUniversity of Salford
t: +44 0161 2953516
email; m.j.harrison-blount@salford.ac.uk | www.salford.ac.uk
Quality improvement is integral to the practice of medicine. Sometimes, QI strays over into clinical research. This presentation provides an overview of the intersection between QI and research
iWantGreatCare's 7th National Symposium - Building fantastic staff morale, improving quality and reducing costs - took place on Tuesday 21st June at The King's Fund, London.
NHS leaders share their experiences of how they are building excellence in their Trust, reducing costs and growing staff morale by listening to the voice of the patient.
View the slides from these well-regarded delegates:
Alwen Williams, Chief Exective, Barts Health NHS Trust
David Behan, Chief Executive, Care Quality Commission
Dr Nadeem Moghal, Medical Director, Barking, Havering and Redbridge University Hospitals NHS Trust
Liz Mouland, Chief Nurse, First Community Health and Care
Jeremy Howick, clinical epidemiologist and philosopher
How graduates can help students gain vital careers skills – a presentation by Professor Ella Ritchie, Deputy Vice-Chancellor at Newcastle University, at Convocation Weekend (18 June 2011).
Slides from Deputy VC Ella Ritchie's report to Convocation on engagement and internationalisation at Newcastle University's Convocation Weekend, 16 June 2012.
Jodhpur National University : Convocation 12jnujodhpur
The first convocation of Jodhpur National University, Jodhpur will be held on March, 24th.2012 at Jodhpur National University Campus, Bornada, Jodhpur.
This presentation by the Bureau of Health Information to the Royal Australasian College of Physicians looks at using clinical outcome data to improve patient care.
It examines:
Why measure and report on performance?
- Accountability and quality improvement
What is performance really?
- It is not a measure of what the system is, it is a measure of how well the system does
Whose performance is it anyway?
- Attributing results to providers, units or sectors requires a careful assessment
Sills MR. Overview of the SAFTINet Program. Presented to the Emergency Department Research Committee, Department of Pediatrics, University of Colorado School of Medicine. 6 January 2015.
Presentation is about the uniqueness of Implementation Research and Role of the Government, specially in Indian context of health programme implementation.
Utilización de la evidencia cualitativa para mejorar la inclusión de las pref...GuíaSalud
Tercera intervención de la Mesa 1 de la Jornada científica GuíaSalud 2017: La implicación de pacientes en el desarrollo de GPC. Una estrategia necesaria para mejorar la toma de decisiones. Simon Lewin
CDC will provide an overview of their WorkLife Wellness Office services and describe how they used the HealthLead accreditation process to provide a framework to assess the comprehensiveness of their new office and existing programs and processes. Also, how the scoring of framework identified strengths and weaknesses and how the assessment plan of action is used for future strategic planning to drive new connections, data sources, and programmatic gaps as they strive to achieve HealthLead Silver. CDC will share specific examples of what was required and shared as part of the HealthLead audit during the presentation.
Evidence for Public Health Decision MakingVineetha K
The presentation gives an overview of evidence based public health with emphasis on the seven steps of EBPH Framework. It also includes the data sources to search for evidence and relevant articles explaining the current trend in decision making. One of the sources of the presentation is from EBPH training series by Rocky Mountain foundation. The link is provided in the end slide. Do contact me if you need any help with the resources.
Measuring and Enhancing Your Academic Medical ImpactMarion Sills
Overview of measuring and enhancing the impact of your scholarly work in academic medicine. The talk reviews how impact is defined and measured, how to improve your own impact metrics and how to describe the impact of your scholarly contributions to science.
Stakeholder Engagement in a Patient-Reported Outcomes Implementation by a Pra...Marion Sills
Kwan BM, Sills MR, Graham D, Hamer MK, Fairclough DL, Hammermeister KE, Kaiser A, Diaz-Perez MJ, Schilling LM. Stakeholder Engagement in a Patient-Reported Outcomes Implementation by a Practice-Based Research Network. JABFM. In Press.
Practice Variability in and Correlates of Patient-Centered Medical Home Chara...Marion Sills
Schilling LM, Sills MR, Fairclough D, Kwan MB. Practice Variability in and Correlates of Patient-Centered Medical Home Characteristics. SAFTINet Convocation. Aurora, Colorado. 13 Feb 2013.
Sills MR. Inpatient capacity margin at children's hospitals during the fall 2009 H1N1 influenza pandemic. Presentation to the Colorado Emergency Medicine Research Center. 14 June 2010.
Patient-reported outcomes for asthma in children and adultsMarion Sills
Patient-reported outcomes for asthma in children and adults. Guided Discussion to Facilitate SAFTINet Stakeholders' Selection of an Asthma PROM. Teleconference. 1 April 2011
Sills MR. Cardiovascular Cohorts PROM Measures Updates and Action Items. Slides for teleconference to facilitate discussion of Cardiovascular PRO Measure Selection by SAFTINet Stakeholder Community. 21 March 2012.
Sills MR. Evolution of PRO Measure for Cardiovascular Cohorts in SAFTINet. Slides for teleconference to facilitate discussion of Cardiovascular PRO Measure Selection by SAFTINet Stakeholders. 2 May 2012.
Sills MR. Medication Adherence PROM Measures Updates and Pilot Results. Slides for teleconference to facilitate discussion of Cardiovascular PRO Measure Selection and Refinement by SAFTINet Stakeholders. 2 July 2012.
Sills MR. Medication Adherence PROM Measures and Self Efficacy. Slides for teleconference to facilitate discussion of Cardiovascular PRO Measure Selection by SAFTINet Stakeholders. 21 May 2012.
Cer safti net overview edrc 1 feb 2011Marion Sills
Sills MR. Overview of Comparative Effectiveness Research Using SAFTINet as an Example. Methods Talk presented to the Emergency Department Research Conference, Department of Pediatrics, 1 February 2011.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
1. Marion R. Sills, MD, MPH
SAFTINet co-Investigator
LEVERAGING SAFTINET
RESOURCES TO
ENHANCE VALUE IN
PERFORMANCE
MEASUREMENT
2. Questions
• In general, what makes a performance measure more/less
actionable? (or valuable)?
• What makes UDS adult weight measure, specifically, more/less actionable?
• How generalizable to other UDS, meaningful use measures?
• What does actionable usually mean?
• What kinds of actions would you take?
• How would we detect action/follow-up?
• What features of a measure or a report would affect actionability?
3. Value of Performance Measures
• Attributes of performance measures related to their value* include:
• the relevance of the measure to a topic of importance* that will inform
important* healthcare decisions
• the scientific soundness of the measure, including validity, accuracy and
reproducibility
• the feasibility of the measure, including logistical and financial burden
• relevance
• scientific soundness
• feasibility*to stakeholders
4. Limitations of Current Measure
• Relevance
• Is the measure easily interpreted?
• What is the significance of the measure to stakeholders?
• What are the policy and financial implications of implementing the
measure? Does it encourage activities that use resources efficiently to
maximize health?
• What is the prevalence and overall impact (health, financial) of the
condition in the population? {selected for this in choosing measure}
• What control does the measured entity have over the condition?
• Will there be wide variations across systems?
• How much room is available for measured entities to improve
performance?
• relevance
• scientific soundness
• feasibility
5. Limitations of Current Measure
• Scientific soundness
• Does the measure precisely evaluate what is actually happening? What
measures of data quality are reported?
• What is the strength of the evidence linking the clinical processes and
outcomes that the measure addresses?
• Does the measure produce reproducible results when repeated in the
same population and setting?
• Does the measure make sense logically and clinically? (validity)
• Is it appropriate to risk-adjust the measure by age or some other variable?
• Are accuracy, reproducibility and validity consistent across different data
systems and settings?
• relevance
• scientific soundness
• feasibility
6. Limitations of Current Measure
• Feasibility
• Does the measure impose an inappropriate burden on health care systems?
• Does the measure have clear specifications for data sources and methods
for data collection and reporting?
• Does the data collection violate accepted standards of member
confidentiality?
• Is the required data logistically feasible to access?
• Is the measure susceptible to manipulation that would be undetectable in
an audit?
• relevance
• scientific soundness
• feasibility
8. Limitations of Current Measure
• Relevance
• Is the measure easily interpreted?
• relevance
• scientific soundness
• feasibility
UDS process measure
Composite measure obfuscates what
portion of the compliance rate
reflects documentation of
• BMI
• follow-up
• underweight or overweight
• by age
• by type: nutrition, exercise
9. Limitations of Current Measure
• Parsing the composite measure may help stakeholders identify
which components contribute to the compliance rate
• Easier to interpret
Adults with > 1 visit
BMI
documented
BMI > 30
Follow-up
documented
10. UDS process measure
Limitations of Current Measure
• Relevance
• What is the significance of the measure to stakeholders?
• Does it target measures of value? Stakeholder-valued process measures
(hypothetical)
Adults with > 1 visit
BMI
documented
Stakeholder-valued outcome measures
BMI > 30
Follow-up
documented
?
11. UDS process measure
Limitations of Current Measure
• Relevance
• What is the significance of the measure to stakeholders?
• Does it target measures of value? Stakeholder-valued process measures
(hypothetical)
Adults with > 1 visit
BMI
documented
?
Stakeholder-valued outcome measures
BMI > 30
Follow-up
documented
Do stakeholders give
equal value to follow-up
documentation in
• a 65 year old with a
BMI of 21 as in
• a 21 year old with a
BMI of 65?
12. UDS process measure
Limitations of Current Measure
• Relevance
• What is the significance of the measure to stakeholders?
• Does it target measures of value? Stakeholder-valued process measures
(hypothetical)
Adults with > 1 visit
BMI
documented
?
Stakeholder-valued outcome measures
BMI > 30
Follow-up
documented
Measure could have
enhanced value if made
concordant with a BMI
cut-off of value to
stakeholders
13. Limitations of Current Measure
• Relevance
• Does the measure encourage activities that use resources efficiently to
maximize health?
• Is the data useful for improving improved performance?
• Aggregate nature of measure makes it hard to use for process
improvement
• cannot compare providers or practices
• thus cannot measure improvement associated with practice-level interventions
• cannot target individual patients for case management or other services
• relevance
• scientific soundness
• feasibility
14. Addressing Relevance-Related Limitations
• Addressing lack of concordance with measures of value
• Add relevant variables to measure
0
10
20
30
40
50
60
70
80
Org 1 Org 2 Org 3 Org 4
UDS Adult Weight Measure Compliance, 2012
15. Addressing Relevance-Related Limitations
• Addressing composite nature of current measure
Parameter Selection
BMI documented
Yes
No
Follow-up documented
Yes
No
Age and BMI parameters
< age 65 AND BMI > 25
> age 65 AND BMI > 30
< age 65 AND BMI < 18.5
> age 65 AND BMI < 22
0%
10%
20%
30%
40%
50%
60%
Org 1 Org 2 Org 3 Org 4
UDS Adult Weight Measure Compliance, 2012
16. Addressing Relevance-Related Limitations
• Addressing lack of concordance with measures of value
0%
10%
20%
30%
40%
50%
60%
Org 1 Org 2 Org 3 Org 4
UDS Adult Weight Measure Compliance, 2012
Parameter Selection
BMI documented
Yes
No
Follow-up documented
Yes
No
Age and BMI parameters
< age 65 AND BMI > 25
> age 65 AND BMI > 30
< age 65 AND BMI < 18.5
> age 65 AND BMI < 22
Age _____ to _____
BMI _____ to _____ Age _____ to _____
BMI _____ to _____
Number of visits in 12 months _____ to _____
Hgb A1C _____ to _____
Systolic BP _____ to _____
Diastolic BP _____ to _____
Hospitalizations in 12 months _____ to _____
Nutrition
Exercise
17. Addressing Utility-Related Limitations
• Addressing aggregate nature of current measure
Population
Practice
Main St Clinic
West Health Practice
Whole Family Center
Casey Cares Clinic
Peaceful Practice
Wellness Center
Provider
Brett Almond
Pat Grant
Darby Eden
Carson Brooke
Harper Keegan
Addison Keith
Kelly Jordan
0
10
20
30
40
50
60
70
Main St Clinic West Health
Practice
Whole Family
Center
Casey Cares
Clinic
Peaceful
Practice
Wellness
Center
0
10
20
30
40
50
60
70
Brett Almond Pat Grant Darby Eden Carson
Brooke
Harper
Keegan
Addison
Keith
Kelly Jordan
19. Limitations of Current Measure
• Scientific soundness
• Does the measure precisely evaluate what is actually happening? What
measures of data quality are reported?
• What is the strength of the evidence linking the clinical processes and
outcomes that the measure addresses?
• Does the measure produce reproducible results when repeated in the
same population and setting?
• Does the measure make sense logically and clinically? (validity)
• Is it appropriate to risk-adjust the measure by age or some other variable?
• Are accuracy, reproducibility and validity consistent across different data
systems and settings?
• relevance
• scientific soundness
• feasibility
20. Limitations of Current Measure
• Scientific soundness: data quality
• If chart-review is used to derive UDS measure
• inter-relater variation:
• measure elements—especially deciding what constitutes
follow-up—are not simple to identify
• observation bias, misclassification
• If EHR is used to derive UDS measure
• clinicians vary
• what justifies clicking a “follow-up done’ checkbox
• how often they forget to click the checkbox
(completeness of data)
• EHRs vary in how easily data is recorded and
extracted
21. Limitations of Current Measure
• Scientific soundness
• Lack of information about data quality in the
measure reporting is a barrier to
• interpreting and using the measure
• fixing data quality issues
• relevance
• scientific soundness
• feasibility
22. Addressing Scientific Soundness-Related
Limitations
• Addressing lack of information about data quality
0
10
20
30
40
50
60
70
Main St Clinic West Health
Practice
Whole Family
Center
Casey Cares
Clinic
Peaceful
Practice
Wellness
Center
Data Quality Elements
Out-of-range values
Height > 260 cm
Height < 60 cm
Weight > 200 kg
Weight < 20 kg
Pregnant males
Missing values
Missing height
Missing weight
Missing BMI
Missing follow-up
Missing provider
Population
Practice
Main St Clinic
West Health Practice
Whole Family Center
Casey Cares Clinic
Peaceful Practice
Wellness Center
Provider
Brett Almond
Pat Grant
Darby Eden
Carson Brooke
Harper Keegan
Addison Keith
Kelly Jordan
23. Limitations of Current Measure
• Feasibility
• Does the measure impose an inappropriate burden on health care systems?
• Does the measure have clear specifications for data sources and methods
for data collection and reporting?
• Does the data collection violate accepted standards of member
confidentiality?
• Is the required data logistically feasible to access?
• Is the measure susceptible to manipulation that would be undetectable in
an audit?
• relevance
• scientific soundness
• feasibility
24. Limitations of Current Measure
• Feasibility
• Chart review of 70 records is resource intensive
• What would be the resource commitment involved
in transitioning to EHR-based reporting of this
measure?
• relevance
• scientific soundness
• feasibility
25. R/QI Committee Process
• Define priorities for addressing limitations
• Refine and finalize scope-of-work for addressing key limitations of
the current UDS measure
• Develop reports that address these limitations
• Define and pursue next steps
• assess changes in relevance, scientific soundness and feasibility
• disseminate findings
• to whom?
• what format?
• possible groundwork for pragmatic trial
• relevance
• scientific soundness
• feasibility
Editor's Notes
To complete column C, the reporting partner reports the number of patients in column B who are compliant for this measure. This is a bit complicated, so the next slide shows this measure visually.
In report format, the measure could be made more relevant through parsing it into more meaningful components and adding parameters to allow the organization to look at measures of value to them.